Evidence map›Paper›PMID 39843407›Full record

ArticleVirulence2025

Xinpeng Liu, Lan Huang, Yang Ye, Haiyi Wang, Min Tang, Fuqiang He, Zijing Xia, Shi Deng, Peng Zhang, Ruiwu Dai and 1 more

Abstract read
In one paragraph

Article in Virulence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xinpeng LiuDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Lan HuangDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Yang YeDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Haiyi WangDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Min TangDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Fuqiang HeDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Zijing XiaDepartment of Rheumatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Shi DengDepartment of Urinary Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Peng ZhangDepartment of Urinary Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ruiwu DaiDepartment of General Surgery, General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Shufang LiangDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0003-1000-7508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The resistance of commonly used clinical antibiotics, such as daptomycin (DAP), has become increasingly serious in the fight against

Indexed as

5'-NucleotidaseBacterial ProteinsImmune EvasionStaphylococcus aureusAnimalsAnti-Bacterial AgentsClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsDaptomycinDrug Resistance, BacterialFemaleGene EditingMiceMutationStaphylococcal InfectionsVirulence5'-NucleotidaseAnti-Bacterial AgentsBacterial ProteinsDaptomycinabscessbase editingnt5 genephagocytosisStaphylococcus aureus

Identifiers

PMID39843407
PMCPMC11759621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.